Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Structural Study of Selectivity Mechanisms for JNK3 and p38α with Indazole Scaffold Probing Compounds
1X-ray Crystallography Core, UF Scripps Biomedical Research.
Medicinal chemists developed thiophene-indazole compounds to selectively inhibit JNK3 and p38α kinases. Crystal structures and simulations revealed key interactions driving inhibitor selectivity, aiding future drug design.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Computational Chemistry
Background:
- Developing selective kinase inhibitors is crucial due to conserved ATP binding sites.
- JNKs and p38α are important kinase targets, with thiophene-indazole scaffolds showing promise for selectivity.
- Previous efforts have identified scaffolds with isoform selectivity for JNKs and selectivity for p38α.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the selectivity of thiophene-indazole compounds for JNK3 and p38α.
- To understand the critical interactions governing the affinity and selectivity of these inhibitors.
- To provide insights for the development of next-generation JNK3 isoform inhibitors.
Main Methods:
- Utilized four thiophene-indazole derived compounds.
- Determined crystal structures of inhibitors bound to JNK3 or p38α.
- Performed molecular dynamics (MD) simulations to analyze binding mechanisms.
Main Results:
- Elucidated specific binding interactions responsible for selectivity between JNK3 and p38α.
- Identified key structural features of the thiophene-indazole scaffold that confer selectivity.
- Provided atomic-level understanding of inhibitor-kinase interactions.
Conclusions:
- The study offers valuable insights into the structure-activity relationships of thiophene-indazole inhibitors.
- Findings will guide the optimization of current lead compounds.
- Facilitates the design of novel, highly selective JNK3 isoform inhibitors.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Ligand Binding and Linkage
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...